Form D — Nexo Therapeutics, Inc.
0001955319-25-000002 · filed 2025-09-17
Offering
- Industry
- Biotechnology
- Exemptions
- 06b
- Total offering
- $60,000,000
- Total sold
- $52,500,001
- Minimum investment
- $0
- Investors
- —
- Sales commission
- —
- Finders' fees
- —
Issuer
- Name
- Nexo Therapeutics, Inc.
- CIK
- 1955319
- Entity
- Corporation
- Jurisdiction
- DELAWARE
- Year incorporated
- 2022
- Address
- 11757 W. KEN CARYL AVENUE
LITTLETON, CO 80127-3719 - Phone
- 303-868-6790
Related persons
May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.
-
Andrew Phillips · Executive OfficerLittleton, CO Find on LinkedIn ↗
-
Ali Behbahani · DirectorLittleton, CO Find on LinkedIn ↗
-
Carlo Rizzuto · DirectorLittleton, CO Find on LinkedIn ↗
View original on SEC EDGAR.